BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22310251)

  • 21. Copper-64-diacetyl-bis(N(4)-methylthiosemicarbazone) pharmacokinetics in FaDu xenograft tumors and correlation with microscopic markers of hypoxia.
    McCall KC; Humm JL; Bartlett R; Reese M; Carlin S
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e393-9. PubMed ID: 22727887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors.
    Abramyuk A; Wolf G; Shakirin G; Haberland U; Tokalov S; Koch A; Appold S; Zöphel K; Abolmaali N
    Acta Radiol; 2010 Sep; 51(7):793-9. PubMed ID: 20583948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM.
    Dehdashti F; Mintun MA; Lewis JS; Bradley J; Govindan R; Laforest R; Welch MJ; Siegel BA
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):844-50. PubMed ID: 12692685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the Tumor Redox Status in Head and Neck Cancer by 62Cu-ATSM PET.
    Tsujikawa T; Asahi S; Oh M; Sato Y; Narita N; Makino A; Mori T; Kiyono Y; Tsuchida T; Kimura H; Fujieda S; Okazawa H
    PLoS One; 2016; 11(5):e0155635. PubMed ID: 27187778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer.
    Takahashi N; Fujibayashi Y; Yonekura Y; Welch MJ; Waki A; Tsuchida T; Sadato N; Sugimoto K; Itoh H
    Ann Nucl Med; 2000 Oct; 14(5):323-8. PubMed ID: 11108159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of tumor hypoxia by 62Cu-ATSM PET/CT as a predictor of response in head and neck cancer: a pilot study.
    Minagawa Y; Shizukuishi K; Koike I; Horiuchi C; Watanuki K; Hata M; Omura M; Odagiri K; Tohnai I; Inoue T; Tateishi U
    Ann Nucl Med; 2011 Jun; 25(5):339-45. PubMed ID: 21327756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular imaging biomarkers of resistance to radiation therapy for spontaneous nasal tumors in canines.
    Bradshaw TJ; Bowen SR; Deveau MA; Kubicek L; White P; Bentzen SM; Chappell RJ; Forrest LJ; Jeraj R
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):787-95. PubMed ID: 25752393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-tumoral distribution of (64)Cu-ATSM: a comparison study with FDG.
    Obata A; Yoshimoto M; Kasamatsu S; Naiki H; Takamatsu S; Kashikura K; Furukawa T; Lewis JS; Welch MJ; Saji H; Yonekura Y; Fujibayashi Y
    Nucl Med Biol; 2003 Jul; 30(5):529-34. PubMed ID: 12831991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1α expression in patients with glioma.
    Tateishi K; Tateishi U; Sato M; Yamanaka S; Kanno H; Murata H; Inoue T; Kawahara N
    AJNR Am J Neuroradiol; 2013 Jan; 34(1):92-9. PubMed ID: 22700754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of PET images of metabolism, proliferation and hypoxia to characterize tumor phenotype in patients with cancer of the oropharynx.
    Nyflot MJ; Harari PM; Yip S; Perlman SB; Jeraj R
    Radiother Oncol; 2012 Oct; 105(1):36-40. PubMed ID: 23068711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting location of recurrence using FDG, FLT, and Cu-ATSM PET in canine sinonasal tumors treated with radiotherapy.
    Bradshaw T; Fu R; Bowen S; Zhu J; Forrest L; Jeraj R
    Phys Med Biol; 2015 Jul; 60(13):5211-24. PubMed ID: 26083082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
    Kitagawa Y; Sano K; Nishizawa S; Nakamura M; Ogasawara T; Sadato N; Yonekura Y
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):63-71. PubMed ID: 12483411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose escalation to high-risk sub-volumes based on non-invasive imaging of hypoxia and glycolytic activity in canine solid tumors: a feasibility study.
    Clausen MM; Hansen AE; Af Rosenschold PM; Kjaer A; Kristensen AT; McEvoy FJ; Engelholm SA
    Radiat Oncol; 2013 Nov; 8():262. PubMed ID: 24199939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Evaluation of Disease Outcome in Solid Tumors Investigated With 64Cu-ATSM PET/CT.
    Lopci E; Grassi I; Rubello D; Colletti PM; Cambioli S; Gamboni A; Salvi F; Cicoria G; Lodi F; Dazzi C; Mattioli S; Fanti S
    Clin Nucl Med; 2016 Feb; 41(2):e87-92. PubMed ID: 26447388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of hypoxia in a feline model of head and neck cancer using ⁶⁴Cu-ATSM positron emission tomography/computed tomography.
    Ballegeer EA; Madrill NJ; Berger KL; Agnew DW; McNiel EA
    BMC Cancer; 2013 Apr; 13():218. PubMed ID: 23631652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of intratumoral FDG and Cu-ATSM distributions in cancer tissue originated spheroid (CTOS) xenografts, a tumor model retaining the original tumor properties.
    Furukawa T; Yuan Q; Jin ZH; Aung W; Yoshii Y; Hasegawa S; Endo H; Inoue M; Zhang MR; Fujibayashi Y; Saga T
    Nucl Med Biol; 2014 Sep; 41(8):653-9. PubMed ID: 24997088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A limited overlap between intratumoral distribution of 1-(5-fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole and copper-diacetyl-bis[N(4)-methylthiosemicarbazone].
    Furukawa T; Yuan Q; Jin ZH; Aung W; Yoshii Y; Hasegawa S; Endo H; Inoue M; Zhang MR; Fujibayashi Y; Saga T
    Oncol Rep; 2015 Sep; 34(3):1379-87. PubMed ID: 26134305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radio-copper-labeled Cu-ATSM: an indicator of quiescent but clonogenic cells under mild hypoxia in a Lewis lung carcinoma model.
    Oh M; Tanaka T; Kobayashi M; Furukawa T; Mori T; Kudo T; Fujieda S; Fujibayashi Y
    Nucl Med Biol; 2009 May; 36(4):419-26. PubMed ID: 19423010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normal FDG distribution patterns in the head and neck: PET/CT evaluation.
    Nakamoto Y; Tatsumi M; Hammoud D; Cohade C; Osman MM; Wahl RL
    Radiology; 2005 Mar; 234(3):879-85. PubMed ID: 15734938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.